Activated alloreactive T-cell

Activated alloreactive T-cells are a specialized subset of T-lymphocytes that have been triggered by the recognition of foreign major histocompatibility complex (MHC) molecules, known as alloantigens. These cells play a central role in the pathophysiology of both acute and chronic graft-versus-host disease (GvHD) following hematopoietic stem cell transplantation, as well as in the rejection of solid organ transplants (1). Upon activation, these T-cells undergo clonal expansion and differentiate into effector cells that release pro-inflammatory cytokines and exert direct cytotoxicity against host or graft tissues (2). Therapeutic targeting of these cells often involves the use of monoclonal antibodies directed against surface markers that are specifically upregulated during activation, such as CD25 or CD26 (3). Other strategies include costimulation blockade, which prevents the necessary secondary signals for T-cell activation, and selective depletion techniques like photodynamic therapy (4). By focusing on the activated subset rather than the entire T-cell population, clinicians aim to reduce the severity of GvHD or rejection while preserving the patient's ability to mount immune responses against pathogens. However, a significant challenge remains in balancing the suppression of alloreactivity with the maintenance of the graft-versus-leukemia effect, which is essential for preventing cancer recurrence in transplant recipients (5). Citations: (1) PubMed: 28232548; (2) NIH/NCBI: NBK538330; (3) EMA/H/C/004074 (Begelomab); (4) Blood Journal: 10.1182/blood-2002-07-2145; (5) StatPearls: NBK538330.

Other names

Alloreactive T-lymphocyteDonor T-cellHost-reactive T-cellAlloantigen-specific T-cellActivated allo-T cell

Selective depletion or functional inhibition of T-lymphocytes that have been activated by non-self (allo) antigens, typically through targeting activation-induced surface markers (e.g., CD25, CD26), blocking interleukin-2 signaling, or interrupting costimulatory pathways required for T-cell expansion.